These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 17701871)

  • 1. Intravenous immunoglobulin therapy for neuromuscular disorders.
    Ross MA
    Semin Neurol; 2007 Sep; 27(4):340-6. PubMed ID: 17701871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consensus statement: the use of intravenous immunoglobulin in the treatment of neuromuscular conditions report of the AANEM ad hoc committee.
    Donofrio PD; Berger A; Brannagan TH; Bromberg MB; Howard JF; Latov N; Quick A; Tandan R
    Muscle Nerve; 2009 Nov; 40(5):890-900. PubMed ID: 19768755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of autoimmune neuromuscular diseases with high-dose intravenous immune globulin.
    Soueidan SA; Dalakas MC
    Pediatr Res; 1993 Jan; 33(1 Suppl):S95-100. PubMed ID: 8433882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intravenous IgG for treatment of neuromuscular diseases].
    Vedeler CA; Mellgren SI; Omdal R; Torbergsen T; Aasly J
    Tidsskr Nor Laegeforen; 2010 Sep; 130(17):1717-20. PubMed ID: 20835282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The use of intravenous immunglobulin in the treatment of autoimmune neuromuscular diseases].
    Molnár MJ
    Ideggyogy Sz; 2006 Mar; 59(3-4):98-106. PubMed ID: 16634454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The current place of high-dose immunoglobulins in the treatment of neuromuscular disorders.
    van der Meché FG; van Doorn PA
    Muscle Nerve; 1997 Feb; 20(2):136-47. PubMed ID: 9040650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Patwa HS; Chaudhry V; Katzberg H; Rae-Grant AD; So YT
    Neurology; 2012 Mar; 78(13):1009-15. PubMed ID: 22454268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders.
    Gürcan HM; Ahmed AR
    Ann Pharmacother; 2007 May; 41(5):812-23. PubMed ID: 17440006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IVIg in myasthenia gravis, Lambert Eaton myasthenic syndrome and inflammatory myopathies: current status.
    Illa I
    J Neurol; 2005 May; 252 Suppl 1():I14-8. PubMed ID: 15959667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin in autoimmune neuromuscular diseases.
    Dalakas MC
    JAMA; 2004 May; 291(19):2367-75. PubMed ID: 15150209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review: the use of rituximab in neuromuscular diseases.
    Ibrahim H; Dimachkie MM; Shaibani A
    J Clin Neuromuscul Dis; 2010 Dec; 12(2):91-102. PubMed ID: 21386778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile.
    Dalakas MC
    Pharmacol Ther; 2004 Jun; 102(3):177-93. PubMed ID: 15246245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunoglobulin therapy of neuromuscular diseases].
    Schuchardt V
    Nervenarzt; 1993 Feb; 64(2):91-7. PubMed ID: 8450900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma exchange in neuroimmunological disorders: part 2. Treatment of neuromuscular disorders.
    Lehmann HC; Hartung HP; Hetzel GR; Stüve O; Kieseier BC
    Arch Neurol; 2006 Aug; 63(8):1066-71. PubMed ID: 16908731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updated consensus statement: Intravenous immunoglobulin in the treatment of neuromuscular disorders report of the AANEM ad hoc committee.
    Tavee J; Brannagan TH; Lenihan MW; Muppidi S; Kellermeyer L; D Donofrio P;
    Muscle Nerve; 2023 Oct; 68(4):356-374. PubMed ID: 37432872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can we face the challenge of expanding use of intravenous immunoglobulin in neurology?
    Elovaara I; Hietaharju A
    Acta Neurol Scand; 2010 Nov; 122(5):309-15. PubMed ID: 20085560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines for the use of intravenous immunoglobulin in the treatment of neurologic diseases.
    Bascić-Kes V; Kes P; Zavoreo I; Lisak M; Zadro L; Corić L; Demarin V;
    Acta Clin Croat; 2012 Dec; 51(4):673-83. PubMed ID: 23540178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and comparison of adverse events for preparations of IVIG in patients with neuromuscular diseases.
    Nadeau JO; Bhibhatbhan A; McDougall D; Toth C
    Clin Neurol Neurosurg; 2010 Jul; 112(6):467-9. PubMed ID: 20227821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin use for neurologic diseases.
    Koski CL; Patterson JV
    J Infus Nurs; 2006; 29(3 Suppl):S21-8. PubMed ID: 16878852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease.
    Thornton CA; Griggs RC
    Ann Neurol; 1994 Mar; 35(3):260-8. PubMed ID: 8122878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.